NVN Liquidation, Inc. Stock

Stocks

NOVN

US66988N2053

Investment Holding Companies

OTC Markets Traded

Latest news: NVN Liquidation, Inc.

24-05-01	NVN Liquidation, Inc. Announces Board Resignations	CI
24-01-16	First Amended Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc.	CI
23-12-19	Modified Disclosure Statement Approved on Interim Basis for NVN Liquidation, Inc.	CI
23-11-30	First Motion for Exclusivity Period Extension Approved For NVN Liquidation, Inc.	CI
23-11-22	Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc.	CI
23-11-12	First Motion for Exclusivity Period Extension Filed by NVN Liquidation, Inc.	CI
23-10-20	Novan, Inc. has Changed its Name to NVN Liquidation, Inc	CI
23-09-27	Novan, Inc. Announces the Resignation of John M. Gay as Chief Financial Officer	CI
23-09-27	Novan, Inc. Announces the Resignation of John M. Gay as Secretary	CI
23-09-26	Ligand Pharmaceuticals Incorporated completed the acquisition of Substantially All of the Assets of Novan, Inc. for $12.2 million.	CI
23-09-12	Motion for Asset Sale Approved for Novan, Inc.	CI
23-09-12	Motion for Asset Sale Approved for Novan, Inc.	CI
23-09-01	Notice of selection of Successful Bidder Filed by Novan, Inc.	CI

More news

Analysts' recommendations: NVN Liquidation, Inc.

23-06-01	Oppenheimer Downgrades Novan to Perform From Outperform, Removes $8 Price Target	MT
23-05-16	Oppenheimer Adjusts Novan Price Target to $8 From $9, Maintains Outperform Rating	MT
22-07-19	Oppenheimer Initiates Coverage on Novan With Outperform Rating, $12 Price Target	MT
21-10-20	Novan : Brookline Capital Starts Novan at Buy With $16 Price Target	MT
21-09-24	Novan : HC Wainwright Adjusts Novan PT to $24 from $28, Keeps Buy Rating	MT

More recommendations

Press Releases: NVN Liquidation, Inc.

23-07-17	Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection	AQ
23-06-16	NOVAN, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
23-06-05	Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders	AQ
23-05-31	Novan Focuses Strategic Direction and Announces Restructuring	AQ
23-05-15	Novan: Q1 Earnings Snapshot	AQ

More press releases

News in other languages: NVN Liquidation, Inc.

21-10-26	Hausse des actions, les résultats en soutien
21-10-26	Point marchés-Hausse des actions, les résultats en soutien
20-10-27	CAC 40 : Les valeurs à suivre à Paris et en Europe
20-10-27	Les valeurs à suivre à Paris et en Europe (actualisé)

More news

Quotes and Performance

1 day

-99.88%

More quotes

Latest insider transactions

Date	Insider	Type	Main position	Quantity	% Market Cap.
6/27/23	A. Sanders	Sell	Director	11,553	0.0412%
6/6/23	Robert Keegan	Exercice	Director	175,294	0.6257%
6/6/23	James Bierman	Exercice	Director	175,294	0.6257%

Transaction History

Shell Companies

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NVN LIQUIDATION, INC.	-99.88%	-99.88%	-	-	28
CHURCHILL CAPITAL CORP XI	+6.83%	+4.71%	-	-	719M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.05%	+0.07%	-	-	648M
CENTIEL AG	+2.91%	+9.28%	+299.50%	-73.72%	630M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.10%	0.00%	-	-	601M
CHURCHILL CAPITAL CORP XII	-0.98%	-1.25%	-	-	591M
CANTOR EQUITY PARTNERS IV, INC.	-0.29%	-0.14%	+1.47%	-	591M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.36%	-1.68%	-	-	550M
NEW AMERICA ACQUISITION I CORP.	-0.18%	-0.44%	-	-	502M
Average	-10.23%	+1.32%	+150.48%	-73.72%	603.92M
Weighted average by Cap.	+1.16%	+1.51%	+155.29%	-73.72%

See all sector performances

Company Profile

NVN Liquidation, Inc., formerly Novan, Inc., has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.

Employees

Sector

Investment Holding Companies

More about the company